MS Research Roundup

June 29, 2015
Mark L. Fuerst

Recent studies on MS are highlighted, including a possible new avenue for future therapies.

Some studies suggest that MS patients have begun to live longer lives over the last 40 to 50 years. New research suggests that MS patients do not live as long as those in the general population, but controlling comorbidities may help improve their survival. On the positive side, MS patients may have lower rates of vascular comorbidities, including hypertension, diabetes, and hyperlipidemia, than the general population, according to another study. And new research on the sex differences in MS may lead to new MS therapies.